CAMURUS AB

Pharmaceutical preparations; pharmaceutical preparations for injection; pharmaceutical preparation for subcutaneous injection; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for the treatment of neuroendocrine tumours; pharmaceutical preparations for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of esophageal bleeding; pharmaceutical preparations for metabolic disorders; pharmaceutical preparations for the treatment of acromegaly; pharmaceutical preparations for the treatment of polycystic liver disease; pharmaceutical preparations for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for the treatment of respiratory distress syndrome; pharmaceutical preparations for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations intended to block growth hormone.; Devices for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; devices for administration of pharmaceuticals for the treatment of tumours; devices for administration of pharmaceuticals for the treatment of carcinoid tumours; devices for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; devices for administration of pharmaceuticals for the treatment of neuroendocrine tumours; devices for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; devices for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; devices for administration of pharmaceuticals for gastrointestinal bleeding disorders; devices for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; devices for administration of pharmaceuticals for the treatment of esophageal bleeding; devices for administration of pharmaceuticals for metabolic disorders; devices for administration of pharmaceuticals for the treatment of acromegaly; devices for administration of pharmaceuticals for the treatment of polycystic liver disease; devices for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; devices for administration of pharmaceuticals for the treatment of respiratory distress syndrome; devices for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; devices for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; devices for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for the treatment of metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; pens for administration of pharmaceuticals for the treatment of tumours; pens for administration of pharmaceuticals for the treatment of carcinoid tumours; pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of esophageal bleeding; pens for administration of pharmaceuticals for metabolic disorders; pens for administration of pharmaceuticals for the treatment of acromegaly; pens for administration of pharmaceuticals for the treatment of polycystic liver disease; pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; pens for administration of pharmaceuticals intended to block growth hormone; devices for subcutaneous administration of pharmaceuticals; devices for parenteral administration of pharmaceuticals; devices for injection of pharmaceutical depots; devices for subcutaneous injection of pharmaceutical depot; devices for parenteral injection of pharmaceutical depot; devices for injection of injection fluids; devices for injection of injection depot; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; pens for subcutaneous administration of pharmaceuticals; pens for parenteral administration of pharmaceuticals; pens for injection of pharmaceutical depots; pens for subcutaneous injection of pharmaceutical depot; pens for parenteral injection of pharmaceutical depot; pens for injection of injection fluids; pens for injection of injection depot; pens for injections; pens for medical uses.

Educational services, namely, conducting educational programs in the field of the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder and patient support options for these conditions; Providing financial information regarding medical benefits and reimbursements available for medical expenses related thereto via a website; insurance services, namely benefits verification in the nature of insurance claims administration; providing online information and financial assistance with insurance benefits and coverage for health care providers and patients for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Providing medical insurance benefit information for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Business administrative services for medical referrals for treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Business administration of patient reimbursement programs for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Medical services; providing medical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals as well as the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Providing on-line non-downloadable software for administering medical benefit and enrolling in benefits patient support program services.

Educational services, namely, conducting educational programs in the field of the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder and patient support options for these conditions; Providing financial information regarding medical benefits and reimbursements available for medical expenses related thereto via a website; insurance services, namely benefits verification in the nature of insurance claims administration; providing online information and financial assistance with insurance benefits and coverage for health care providers and patients for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Providing medical insurance benefit information for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Business administrative services for medical referrals for treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Business administration of patient reimbursement programs for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Medical services; providing medical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals as well as the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Providing on-line non-downloadable software for administering medical benefit and enrolling in benefits patient support program services.

Educational services, namely, conducting educational programs in the field of the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder and patient support options for these conditions; Providing financial information regarding medical benefits and reimbursements available for medical expenses related thereto via a website; insurance services, namely benefits verification in the nature of insurance claims administration; providing online information and financial assistance with insurance benefits and coverage for health care providers and patients for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Providing medical insurance benefit information for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Business administrative services for medical referrals for treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Business administration of patient reimbursement programs for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Medical services; providing medical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals as well as the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorder; Providing on-line non-downloadable software for administering medical benefit and enrolling in benefits patient support program services.

Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of sustained or extended release drug delivery compounds that provide sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; lipid-based drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders administered via subcutaneous injection; veterinary vaccines; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; dietary supplements for human beings and animals; medical plasters; gauze and bandages for dressings; teeth filling material; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides

Pharmaceutical preparations for injection for the treatment of Polycystic Kidney Disease (PKD); pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone; Medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of carcinoid tumours; medical devices being infusion and injection devices for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of esophageal bleeding; medical devices being infusion and injection devices for administration of pharmaceuticals for metabolic disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acromegaly; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of polycystic liver disease; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; medical devices being infusion and injection devices for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; microneedle dermal pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of carcinoid tumours; microneedle dermal pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; microneedle dermal pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of esophageal bleeding; microneedle dermal pens for administration of pharmaceuticals for metabolic disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of acromegaly; microneedle dermal pens for administration of pharmaceuticals for the treatment of polycystic liver disease; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; microneedle dermal pens for administration of pharmaceuticals intended to block growth hormone; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; devices for injection of pharmaceutical depots; devices for subcutaneous injection of pharmaceutical depot; devices for parenteral injection of pharmaceutical depot; devices for injection of pharmaceuticals and medical injection fluids; devices for injection of injection depot being pharmaceuticals; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; microneedle dermal pens for subcutaneous administration of pharmaceuticals; microneedle dermal pens for parenteral administration of pharmaceuticals; microneedle dermal pens for injection of pharmaceutical depots; microneedle dermal pens for subcutaneous injection of pharmaceutical depot; microneedle dermal pens for parenteral injection of pharmaceutical depot; microneedle dermal pens for injection of injection fluids; microneedle dermal pens for injection of injection depot; microneedle dermal pens for injections; microneedle dermal pens for medical uses

Pharmaceutical preparations for injection for the treatment of Polycystic Kidney Disease (PKD); pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone; Medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of carcinoid tumours; medical devices being infusion and injection devices for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of esophageal bleeding; medical devices being infusion and injection devices for administration of pharmaceuticals for metabolic disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acromegaly; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of polycystic liver disease; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; medical devices being infusion and injection devices for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; microneedle dermal pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of carcinoid tumours; microneedle dermal pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; microneedle dermal pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of esophageal bleeding; microneedle dermal pens for administration of pharmaceuticals for metabolic disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of acromegaly; microneedle dermal pens for administration of pharmaceuticals for the treatment of polycystic liver disease; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; microneedle dermal pens for administration of pharmaceuticals intended to block growth hormone; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; devices for injection of pharmaceutical depots; devices for subcutaneous injection of pharmaceutical depot; devices for parenteral injection of pharmaceutical depot; devices for injection of pharmaceuticals and medical injection fluids; devices for injection of injection depot being pharmaceuticals; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; microneedle dermal pens for subcutaneous administration of pharmaceuticals; microneedle dermal pens for parenteral administration of pharmaceuticals; microneedle dermal pens for injection of pharmaceutical depots; microneedle dermal pens for subcutaneous injection of pharmaceutical depot; microneedle dermal pens for parenteral injection of pharmaceutical depot; microneedle dermal pens for injection of injection fluids; microneedle dermal pens for injection of injection depot; microneedle dermal pens for injections; microneedle dermal pens for medical uses

Pharmaceutical preparations for injection for the treatment of Polycystic Kidney Disease (PKD); pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone; Medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of carcinoid tumours; medical devices being infusion and injection devices for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of esophageal bleeding; medical devices being infusion and injection devices for administration of pharmaceuticals for metabolic disorders; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acromegaly; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of polycystic liver disease; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; medical devices being infusion and injection devices for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; medical devices being infusion and injection devices for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; microneedle dermal pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of carcinoid tumours; microneedle dermal pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; microneedle dermal pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; microneedle dermal pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of esophageal bleeding; microneedle dermal pens for administration of pharmaceuticals for metabolic disorders; microneedle dermal pens for administration of pharmaceuticals for the treatment of acromegaly; microneedle dermal pens for administration of pharmaceuticals for the treatment of polycystic liver disease; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; microneedle dermal pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; microneedle dermal pens for administration of pharmaceuticals intended to block growth hormone; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; devices for injection of pharmaceutical depots; devices for subcutaneous injection of pharmaceutical depot; devices for parenteral injection of pharmaceutical depot; devices for injection of pharmaceuticals and medical injection fluids; devices for injection of injection depot being pharmaceuticals; medical devices being infusion and injection devices for subcutaneous administration of pharmaceuticals; medical devices being infusion and injection devices for parenteral administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; microneedle dermal pens for subcutaneous administration of pharmaceuticals; microneedle dermal pens for parenteral administration of pharmaceuticals; microneedle dermal pens for injection of pharmaceutical depots; microneedle dermal pens for subcutaneous injection of pharmaceutical depot; microneedle dermal pens for parenteral injection of pharmaceutical depot; microneedle dermal pens for injection of injection fluids; microneedle dermal pens for injection of injection depot; microneedle dermal pens for injections; microneedle dermal pens for medical uses

Devices for subcutaneous administration of drugs sold empty; injection devices for parenteral administration of drugs; injection devices for drug depot injection; injection devices for subcutaneous drug depot injection; injection devices for parenteral drug depot injection; injection devices for administration of solution for injection; injection devices for administration of drug depot injection; syringes for subcutaneous administration of drugs; syringes for parenteral administration of drugs; syringes for drug depot injection; syringes for subcutaneous drug depot injection; syringes for parenteral drug depot injection; syringes for administration of solutions for injection; syringes for administration of drug depot injection; syringes for injections; syringes for medical purposes; medical apparatus and instruments, namely, needles for medical purposes

Devices, namely, injection instruments with needles and injection instruments without needles for subcutaneous administration of drugs; devices, namely, injection instruments with needles and injection instruments without needles for parenteral administration of drugs; devices, namely, injection instruments with needles and injection instruments without needles for drug depot injection; devices, namely, injection instruments with needles and injection instruments without needles for subcutaneous drug depot injection; devices, namely, injection instruments with needles and injection instruments without needles for parenteral drug depot injection; devices, namely, injection instruments with needles and injection instruments without needles for administration of solution for injection; devices, namely, injection instruments with needles and injection instruments without needles for administration of drug depot injection; medical syringes for subcutaneous administration of drugs; medical syringes for parenteral administration of drugs; medical syringes for drug depot injection; medical syringes for subcutaneous drug depot injection; medical syringes for parenteral drug depot injection; medical syringes for administration of solutions for injection; medical syringes for administration of drug depot injection; medical syringes for injections; syringes for medical purposes; medical apparatus and instruments, namely, needles for medical purposes; dropping pipettes for medical purposes

Pharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; veterinary pharmaceutical preparations, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; sanitary preparations for medical purposes; dietetic substances, namely dietetic beverages and dietetic sugar adapted for medical use, namely, for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; plasters for medical purposes, materials for dressings, namely, medical dressings, all for the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, for the treatment of opiate and chemical addictions, for the treatment of co-morbidities associated with substance use disorders, for the treatment of mental health diseases and disorders, for the treatment of central nervous system diseases and disorders, and for the management and relief of pain; disinfectants; preparations for destroying vermin; fungicides, herbicides; Medical services; veterinary services; consultancy relating to medicines in the nature of providing medical consultancy services; Scientific and technological services and research, development and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicines, all for use in the fields of treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, treatment of opiate and chemical addictions, treatment of co-morbidities associated with substance use disorders, treatment of mental health diseases and disorders, treatment of central nervous system diseases and disorders, and management and relief of pain; chemical laboratories; chemical research, chemical analysis; research in the fields of medicines, foods, cosmetics and biotechnology; development of technical know-how, namely, technical advice, information, support and consultancy namely, scientific research, analysis and testing in the field of pharmaceutical preparations and medicine, all in the fields of the treatment of substance use disorders, substance dependence, substance withdrawal, substance addiction, and substance overdose, the treatment of opiate and chemical addictions, the treatment of co-morbidities associated with substance use disorders, the treatment of mental health diseases and disorders, the treatment of central nervous system diseases and disorders, and management and relief of pain

Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of sustained or extended release drug delivery compounds that provide sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; lipid-based drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders administered via subcutaneous injection; veterinary vaccines; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; medical plasters; gauze and bandages for dressings; teeth filling material; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; Bleaching preparations for laundry use; substances for laundry use, namely, starch, detergent and fabric softener; cleaning, polishing, scouring and abrasive preparations; non- medicated bath soap; perfumery, essential oils, cosmetics, hair lotions; dentifrices; Licensing of intellectual property; Medical services; providing of information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Chemical laboratories; chemical research, chemical analysis; research and development in the fields of medicines, foods, cosmetics and biotechnology

[ "Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of sustained or extended release drug delivery compounds that provide sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; lipid-based drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders administered via subcutaneous injection; veterinary vaccines; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; medical plasters; gauze and bandages for dressings; teeth filling material; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides" ]; [ Bleaching preparations for laundry use; substances for laundry use, namely, starch, detergent and fabric softener; cleaning, polishing, scouring and abrasive preparations; non- medicated bath soap; perfumery, essential oils, cosmetics, hair lotions; dentifrices ]; Licensing of intellectual property; Medical services; providing of information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Chemical laboratories; chemical research, chemical analysis; research and development in the fields of medicines, foods, cosmetics and biotechnology

[ Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; subcutaneous drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of subcutaneous compounds that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sustained or extended release drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders; drug delivery agents in the form of sustained or extended release drug delivery compounds that provide sustained or extended release of the active ingredients for a wide variety of pharmaceuticals; lipid-based drug delivery agents sold as a component of pharmaceutical preparations for the treatment of genetic, metabolic, endocrine, cardiovascular, oncological, inflammatory, respiratory, neurological, hormonal, cognitive, and substance abuse related diseases and disorders administered via subcutaneous injection; veterinary vaccines; sanitary preparations for medical use; dietetic foods adapted for medical use; food for babies; medical plasters; gauze and bandages for dressings; teeth filling material; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides ]; [ Bleaching preparations for laundry use; substances for laundry use, namely, starch, detergent and fabric softener; cleaning, polishing, scouring and abrasive preparations; non- medicated bath soap; perfumery, essential oils, cosmetics, hair lotions; dentifrices ]; Licensing of intellectual property; Medical services; providing of information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Chemical laboratories; chemical research, chemical analysis; research and development in the fields of medicines, foods, cosmetics and biotechnology

Pharmaceutical preparations for internal use only used to treat substance abuse and drug addiction; Scientific and technological services, namely research and development of vaccines and medicines, conducting clinical trials for others, pharmaceutical research and development, development of pharmaceutical preparations and medicines, pharmaceutical drug development services

[ Pharmaceutical preparations and substances adapted for medical use, namely, preparations for treatment of drug addicted patients, disorders in the mouth, cancer, infection, central nervous system disorders, pain, inflammation, immunological disease, hormonal disorders, growth disorders, diabetic and metabolic conditions and lipid based drug delivery agents sold as a component of various active drugs, namely, tablets, patches, capsules, intravenous, oral solutions, parenteral solutions, and suppositories for human use; veterinary preparations, namely, preparations for treatment of drug addicted patients, disorders in the mouth, cancer, infection, central nervous system disorders, pain, inflammation, immunological disease, hormonal disorders, growth disorders, diabetic and metabolic conditions and lipid based drug delivery agents sold as a component of various active drugs, namely, tablets, patches, capsules, intravenous, oral solutions, parenteral solutions, and suppositories for veterinary use, and sanitary preparations for medical purposes; food for babies; medical plasters, materials for dressings, namely, gauze and material for surgical and wound dressings; material for stopping teeth; dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides ]; [ Soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices ]; [ Licensing of know-how in the field of pharmaceutical manufacture and intellectual property rights ]; Medical services; providing of know-how in the field of pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Chemistry services, namely, chemical research and analysis, technical consulting and medical and scientific research in the pharmaceutical, [ foodstuff, cosmetical ] and biotechnical fields; chemical research, chemical analysis; research and development in the fields of medicines, [ foods, cosmetics ] and biotechnology

Class 005: Lipid based drug delivery agents sold as a component of various active drugs, namely, tablets, patches, capsules, intravenous, oral solutions, parenteral solutions, [ and suppositories ] for human and veterinary use

[ pharmaceutical preparations for the treatment of cancer, infection, central nervous system disorders, pain, inflammation, immunological disease, hormonal disorders, growth disorders, diabetic and metabolic conditions; veterinary preparations for the treatment of cancer, infections, central nervous system disorders, pain, inflammation, immunological disease, hormonal disorders, growth disorders, diabetic and metabolic conditions; sanitary preparations for medical use; material for stopping teeth ] | [ chemical laboratories, ] chemical research, chemical analysis; research within the pharmaceutical, [ cosmetic ] and biotechnical fields | medical services and assistance, namely providing counseling and information concerning drug delivery systems and the treatment of illnesses by means of carrying agents for drugs | licensing of intellectual property

[ meat, fish for food purposes, poultry and game for food, meat extracts, preserved, dried and processed fruits and vegetables, jellies, jams, fruit sauces, eggs, milk and dairy products excluding ice cream, ice milk and frozen yogurt, and edible oils and fats ]; [ pharmaceutical preparations for the treatment of psoriasis, and gastric ulcers, sanitizers for household use, dietary substances, namely, supplements, capsules and pills, baby food, medical plaster, surgical, wound and burn dressings, material for stopping teeth, all purpose disinfectants, preparations for destroying vermin, and fungicides and herbicides for domestic and agricultural use ]; [ skin soap, perfume, essential oils for personal use, cosmetics, namely, skin care creams and ointments, hair lotions and dentifrices ]; licensing of skin soap, perfume, essential oils for personal use, cosmetics, namely, skin care creams and ointments, hair lotions and dentifrices, pharmaceutical preparations for the treatment of psoriasis, gastric ulcers, sanitizers for household use, dietary substances, namely, supplements, capsules and pills, baby food, medical plaster, surgical, wound and burn dressings, material for stopping teeth, all purpose disinfectants, preparations for destroying vermin, and fungicides and herbicides for domestic and agricultural use, meat, fish for food purposes, poultry and game for food, meat extracts, preserved, dried and processed fruits and vegetables, jellies, jams, fruit sauces, eggs, milk and dairy products excluding ice cream, ice milk and frozen yogurt, and edible oils and fats; and supplying prescription drugs to health plan participants for the funding organization; [ chemical laboratories, ] chemical research, chemical analysis, [ medical services, ] research in the field of pharmaceutical products, [ food, cosmetics, ] and biotechnology for others

pharmaceutical and veterinary preparations, namely, carrying agents for pharmaceutical and veterinary drugs and nutritional agents in the nature of nutritional supplements for oral, rectal, topical and parenteral use; chemical diagnostic reagents for pharmaceutical and veterinary purposes; artificial saliva for pharmaceutical and veterinary purposes; micro-encapsulated liquid crystals for use as delivery systems for pharmaceutical and veterinary products; dietary supplements for medical use; medical plasters; all purpose disinfectants; carrying agents for pharmaceutical and veterinary drugs for bone regeneration; artificial formable bone matrix for human or animal bone replacement or reconstruction of bone tissue

[ pharmaceutical and veterinary preparations for maintenance, prevention and/or treatment purposes, namely, carrying agents for pharmaceutical and veterinary drugs and nutritional agents consisting of lipids for oral, rectal, topical and parenteral use; chemical diagnostic reagents for pharmaceutical and veterinary purposes; artificial saliva for pharmaceutical and veterinary purposes; dietary supplements for medical use; medical plasters; all purpose disinfectants ]; [ cosmetic products for skin care, namely, ointments, lotions, creams and gels, skin soap, shaving foam, shaving soap, perfumes ]; [ chemical reagents for scientific or research use; carrying agents for chemical substances for analysis in laboratories for scientific or research use; carrying agents for industrial chemicals for use in the pharmaceutical and foodstuff industry; artificial saliva for industrial, scientific and research use; encapsulated chemicals for use as delivery systems for biologically active substances for industrial and laboratory use; micro-encapsulated liquid crystals for use as a vehicle in the field of in vetro cell and tissue culture conveyance of biologically active substances for scientific or research use; micro-encapsulated liquid crystals for use as delivery systems for cosmetic products; micro-encapsulated liquid crystals for use as delivery systems for pharmaceutical and veterinary products ]; [ chemical laboratories; chemical research; chemical analysis; ] medical assistance, namely, providing counseling and information concerning drug delivery systems and the treatment of illnesses by means of carrying agents for drugs; scientific research and product research and development within the pharmaceutical, foodstuff, cosmetics and biotechnical fields; supplying and/or licensing of know-how concerning drug delivery systems

chemical diagnostic reagents for pharmaceutical and veterinary purposes; and artificial saliva for pharmaceutical and veterinary purposes; chemical preparations for scientific or research use (other than for medical or veterinary use); chemical reagents for scientific or research use (other than for medical or veterinary purposes); chemical substances for analysis in laboratories for scientific or research use (other than for medical or veterinary purposes); industrial chemicals for use in the manufacture of pharmaceuticals and foods; and artificial saliva for industrial, scientific, and research use

Pharmaceutical preparations for * local treatment of pain associated with oral mucositis that is administered through a device, * [ the treatment of inflammatory and infectious diseases and diseases in the oral cavity; Veterinary preparations for inflammatory and infectious diseases and diseases in the oral cavity for pets and livestock ] * none of the aforesaid goods in relation to gynecological pharmaceutical preparations or hygienic products related thereto *; [ Scientific and technological services and research and design in the field of the development of veterinary medicines and human pharmaceuticals for the treatment of inflammatory and infectious diseases and diseases in the oral cavity ]

chemical diagnostic reagents for pharmaceutical and veterinary purposes; and artificial saliva for pharmaceutical, veterinary, industrial and research purposes; chemical preparations for research use (other than for medical or veterinary use); chemical reagents for research use (other than for medical or veterinary purposes); chemical substances for analysis in laboratories for research use (other than for medical or veterinary purposes); and industrial chemicals for use in the manufacture of pharmaceuticals and foods; all related to saliva substitutes